PRNewswire

SINGAPORE, May 20, 2024 /PRNewswire/ -- OKX, a leading Web3 technology company, has issued updates for May 20, 2024.

OKX DEX Incorporates ChangeNOW's Cross-Chain Bridges: Empowering the OKX Web3 Community with Simplified Cross-Chain Interactions

OKX today announced that its DEX aggregator has successfully integrated ChangeNOW's cross-chain bridges,... (continue reading...)

BORDEAUX, France, May 20, 2024 /PRNewswire/ -- TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]

Parkinson's Disease is a progressive neurological disease affecting more than 10 million people worldwide[2] with prevalence doubling in the last 25 years.[3] The complex disease... (continue reading...)

International Tea Day – 21st May 2024: Brits Need To Get Savvy On The Hydration And Performance Boosting Properties Behind Tea Before A Workout

LONDON, May 20, 2024 /PRNewswire/ -- Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel – www.teaadvisorypanel.com - reveals some fascinating insights into... (continue reading...)

CHONGQING, China, May 20, 2024 /PRNewswire/ -- A news report from iChongqing— On May 18, the 2024 Land-Sea Economic Forum, themed "China, an Opportunity: New Era of Brand Globalization," was held at the Chongqing Yuelai International Convention Center.

The forum hosted more than 200 guests from over 20 countries, including Singapore, the United... (continue reading...)

YONGIN, South Korea, May 20, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval.

With this approval, development of 'GC1130A' is expected to accelerate with multinational clinical trials commencing this year. Clinical trial sites have been set... (continue reading...)